Common use of Royalty Payments Clause in Contracts

Royalty Payments. Running royalties shall be payable on a quarterly basis, within sixty (60) days after the end of each Fiscal Quarter, based upon the Net Sales during such Fiscal Quarter, commencing with the Fiscal Quarter in which the First Commercial Sale of the Licensed Product is made or a further sublicense agreement is executed. Royalties shall be calculated in accordance with U.S. generally accepted accounting principles consistently applied and consistent with the terms of this Article IV.

Royalty Payments. Running royalties shall be payable on a quarterly basis, within sixty (60) days after the end of each Fiscal Calendar Quarter, based upon the Net Sales during such Fiscal Calendar Quarter, commencing with the Fiscal Quarter in which the First Commercial Sale of the Licensed Product is made or a further sublicense agreement is executed. Royalties shall be calculated in accordance with U.S. generally accepted accounting principles consistently applied GAAP and consistent with the terms of this Article IV7. Only one royalty payment shall be due on Net Sales even though the sale or use of the Licensed Product may be covered by more than one Patent or Know-How in a country.

Royalty Payments. Running royalties Royalties shall be payable on a quarterly basis, within sixty (60) days after the end of each Fiscal Quartercalendar quarter of each Calendar Year, based upon the Net Sales during such Fiscal Quarter, commencing with the Fiscal Quarter in which the First Commercial Sale of the Licensed Product is made or a further sublicense agreement is executedquarter. Royalties shall be calculated in accordance with U.S. generally accepted accounting principles consistently applied GAAP and consistent with the terms of this Article IVARTICLE 7. Only one royalty payment shall be due on Net Sales even though the sale or use of a Licensed Product may be covered by more than one Patent or Know-How in a country.

Royalty Payments. Running royalties shall be payable on a quarterly basis, within sixty thirty (6030) days after the end of each Fiscal Calendar Quarter, based upon the aggregate Net Sales during such Fiscal Calendar Quarter, commencing with the Fiscal Quarter in which the First Commercial Sale of the Licensed Product is made or a further sublicense agreement is executed. Royalties shall be calculated in accordance with U.S. generally accepted accounting principles consistently applied IFRS and consistent with the terms of this Article IVARTICLE 8. Only one royalty payment shall be due on Net Sales even though the sale or use of a Licensed Product may be covered by more than one Licensed Patent or item of Licensed Know-How in the Territory.

Royalty Payments. Running royalties based upon the Net Sales during a Calendar Quarter due pursuant to Section 6.2 or 6.4 shall be payable by Licensee on a quarterly Calendar-Quarter basis, within sixty thirty (6030) days after the end of each Fiscal such Calendar Quarter, based upon the Net Sales during such Fiscal Quarter, commencing with the Fiscal Quarter in which the First Commercial Sale of the Licensed Product is made or a further sublicense agreement is executed. Royalties shall be calculated in accordance with U.S. United States generally accepted accounting principles consistently applied and consistent with the terms of this Article IVVI. Only one royalty payment shall be due hereunder on Net Sales, even though the Manufacture, sale or use of the Licensed Product may be covered by more than one Patent in a country.

Royalty Payments. Running royalties shall be payable on a quarterly basis, within sixty (60) days after the end of each Fiscal Quartercalendar quarter, based upon the Net Sales during such Fiscal Quartercalendar quarter, commencing with the Fiscal Quarter calendar quarter in which the First Commercial Sale first commercial sale of the Licensed a Pfizer Product is made or a further sublicense agreement is executedmade. Royalties shall be calculated in accordance with U.S. generally accepted accounting principles consistently applied GAAP and consistent with the terms of this Article IV4.

Royalty Payments. Running royalties shall be payable on a quarterly basis, within sixty (60) days after the end of each Fiscal Quartercalendar quarter, based upon the Net Sales during such Fiscal Quartercalendar quarter, commencing with the Fiscal Quarter calendar quarter in which the First Commercial Sale of the Licensed a Unilateral Product is made or a further sublicense agreement is executedmade. Royalties shall be calculated in accordance with U.S. generally accepted accounting principles consistently applied GAAP and consistent with the terms of this Article IV3. Only one royalty payment will be due on Net Sales of a given Unilateral Product even though the manufacture, sale or use of such Unilateral Product may be covered by more than one intellectual property right in a country.

Royalty Payments. Running royalties shall be payable on a quarterly basis, within sixty forty-five (6045) days after the end of each Fiscal Quartercalendar quarter, based upon the Net Sales during such Fiscal Quartercalendar quarter, commencing with the Fiscal Quarter calendar quarter in which the First Commercial Sale of the Licensed a Unilateral Product is made or a further sublicense agreement is executedmade. Royalties shall be calculated in accordance with U.S. generally accepted accounting principles consistently applied GAAP and consistent with the terms of this Article IV3. Only one royalty payment will be due on Net Sales of a given Unilateral Product even though the manufacture, sale or use of such Unilateral Product may be covered by more than one intellectual property right in a country.

Royalty Payments. Running royalties shall be payable on a quarterly basis, within sixty (60) days after the end of each Fiscal Quartercalendar quarter, based upon the Net Sales during such Fiscal Quartercalendar quarter, commencing with the Fiscal Quarter calendar quarter in which the First Commercial Sale first commercial sale of the Licensed a Celldex Product is made or a further sublicense agreement is executedmade. Royalties shall be calculated in accordance with U.S. generally accepted accounting principles consistently applied GAAP and consistent with the terms of this Article IV4.